The 3rd Global Insight Conference on Breast Cancer has been developed more than 15 years ago to specifically provide the audience of breast cancer professionals and scientists with education and discussion on progress in the field. The faculty of international experts was selected to present the most exciting areas of innovation related to breast cancer and to discuss issues of significant controversy. Breast cancer represents the front runner in cancer research in many aspects. The Programme of this Conference includes lectures on molecular characterization, epidemiology, detection and diagnosis, metastatic breast cancer, updated treatments of early and advanced disease, surgery & radiotherapy, management of difficult cases and hereditary syndromes.
We welcome medical oncologists, pathologists, breast surgeons, radiation oncologists and basic scientists to listen to breast cancer leaders and to exchange experiences in a friendly atmosphere. Taking advantage of the unique offerings of Valencia, there will be a limited number of attractive options for those wishing to extend their stay and bring their families with pre and post tours of Valenia. Leisure time activities for delegates and guests will be offered to take full advantage of Valencia.
Mark your calendars now and stay tuned for more information. See you soon in Valencia, Spain.
More than 35 of the top lung cancer researchers in the United States, dubbed the lung cancer “Dream Team,” are coming together to work on one of the most difficult-to-treat lung cancers – those that have a mutation in a gene called KRAS.
Hormone therapy has long been the center of care for prostate cancer and helps many men diagnosed with the disease live longer. Such treatments reduce or block the production of androgens, the male sex hormones that help prostate cells grow and function, but which also fuel cancer cell growth.
Estrogen is an important female hormone that signals the breasts to form during puberty. It's a necessity for normal mammary gland development. Yet, in some cases, the hormone also helps abnormal breast cells to grow, giving rise to the most common subtype of breast cancer, called estrogen receptor-positive (ER-positive) disease.
Colorectal cancer incidence and death rates in the United States have declined significantly in recent decades. But not every part of the country has benefitted equally.
The U.S. Preventive Services Task Force (USPSTF) last week released draft recommendations around the use of aspirin to help prevent disease, including both cardiovascular disease (heart attacks and strokes) and colorectal cancer. The inclusion of colorectal cancer as part of these guidelines is a first.
Copyrights © 2016-17 Innovinc Pvt Ltd All Rights Reserved